115 results
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
15 May 24
Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
9:01am
Litigation Reform Act of 1995. All statements other than statements of current or historical fact contained in this press release, including statements
424B3
ATXI
Avenue Therapeutics Inc
10 May 24
Prospectus supplement
4:53pm
-LOOKING STATEMENTS
This prospectus contains predictive or “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act
424B5
ATXI
Avenue Therapeutics Inc
10 May 24
Prospectus supplement for primary offering
4:52pm
of the Private Securities Litigation Reform Act of 1995. All statements other than statements of current or historical fact contained in this prospectus … -looking statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
Securities Litigation Reform Act of 1995. All statements other than statements of current or historical fact contained in this press release, including
8-K
EX-99.1
mmmt0682w fz0
26 Apr 24
Avenue Therapeutics Announces Reverse Stock Split
4:39pm
8-K
EX-99.1
prgpr hvyazi
18 Mar 24
Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
4:10pm
8-K
8lq35eirnm1 4fv6m9n
15 Mar 24
Other Events
7:15am
424B3
hlbagten 0k
2 Feb 24
Prospectus supplement
12:00am
8-K
EX-99.1
tiotdqdg84753buvq
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
5xuy 372gwp9
24 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
1:19pm
8-K
EX-99.1
solew72
13 Nov 23
Avenue Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
4:10pm
8-K
EX-99.2
t9svrwu klw1
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-10.2
0pja2lbwlto7 xm
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-4.4
nfcch 0j6
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-99.1
j8j5rvpharaue6i5kpw
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
424B4
5qo1cnh7x6orn81swsc
2 Nov 23
Prospectus supplement with pricing info
9:00am